Option Care Health to be acquired by McKesson and CD&R in $5.8 billion deal
Option Care Health announced an agreement to be bought by McKesson and private‑equity firm Clayton, Dubilier & Rice. The transaction values the home‑infusion provider at about $5.8 billion, or $32.05 per share, representing roughly a 37% premium. CD&R will own 51% of the combined company and McKesson 49%, with a future right for McKesson to purchase CD&R’s stake. The deal is expected to close in the first half of 2027 pending shareholder and regulatory approvals.
Why it matters
The company’s shareholders will receive cash at $32.05 per share, a premium to the prior close, according to the press release. Completion of the transaction depends on shareholder votes and regulator sign‑off, which could affect timing and certainty of the payout.
Key facts
- 1Option Care Health agreed to be acquired for $32.05 per share in cash. finance.yahoo.com
- 2The deal values the company at approximately $5.8 billion including debt. finance.yahoo.com
- 3The transaction represents a premium of about 37% over the previous day’s closing price. finance.yahoo.com
- 4CD&R will hold 51% of the company and McKesson 49% after the transaction. finance.yahoo.com
- 5McKesson will invest $1.4 billion for its 49% stake. finance.yahoo.com
- 6The deal is expected to close in the first half of 2027, subject to shareholder and regulatory approvals. finance.yahoo.com
Open questions
- Material 1 reports a valuation of “more than $5 billion” and an enterprise value of $4.6 billion including $1.2 billion of debt, which differs from the $5.8 billion figure in later materials.
Summary written by AlphAI from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.